Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 4/20 | 0.88 |
| ▸ | AURKA | O14965 | 2/20 | 0.88 |
| ▸ | CHAT | P28329 | 2/20 | 0.88 |
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.88 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.88 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.88 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coenzyme_A SCHEMBL16974425 | 0.95 | EP300 (0.88) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL2831401 | 0.95 | EP300 (0.88) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL2833078 | 0.95 | EP300 (0.88) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL2833005 | 0.95 | EP300 (0.88) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL16974417 | 0.94 | EP300 (0.87) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL15969462 | 0.94 | EP300 (0.89) | EP300AURKACHATNAA50KAT5 | |
| SCHEMBL16216009 | 0.94 | EP300 (0.86) | EP300AURKACHATNAA50KAT5 | |
| SCHEMBL16216000 | 0.94 | EP300 (0.86) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL13500623 | 0.94 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL26753 | 0.94 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103733-A1 | METHODS AND ORGANISMS WITH INCREASED CARBON FLUX EFFICIENCIES | AGAIN BIO APS (DK) | 2026-04-16 | — | — | US | disclosed |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | AGAIN BIO APS (DK) | 2026-01-29 | — | — | US | disclosed |
| US-20250388910-A1 | METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL | AGAIN BIO APS (DK) | 2025-12-25 | — | — | US | disclosed |
| US-12503711-B2 | Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism | GENOMATICA, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | AGAIN BIO APS (DK) | 2025-11-27 | — | — | US | disclosed |
| US-12435346-B2 | Methods and organisms with increased carbon flux efficiencies | GENOMATICA, INC. (US) | 2025-10-07 | — | — | US | disclosed |
| US-12398396-B2 | Methods for enhancing microbial production of specific length fatty alcohols in the presence of methanol | GENOMATICA, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-12312627-B2 | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds | GENOMATICA, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| EP-3074504-B1 | METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL | GENOMATICA INC (US) | 2024-12-25 | — | — | EP | disclosed |
| EP-4421181-A2 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | Genomatica, Inc. (US) | 2024-08-28 | — | — | EP | disclosed |
| US-20110129904-A1 | METHODS AND ORGANISMS FOR CONVERTING SYNTHESIS GAS OR OTHER GASEOUS CARBON SOURCES AND METHANOL TO 1,3-BUTANEDIOL | GENOMATICA, INC. | 2011-06-02 | — | — | US | disclosed |
| US-20110124911-A1 | SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID | GENOMATICA, INC. | 2011-05-26 | — | — | US | disclosed |
| WO-2011047101-A1 | MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCINE AND RELATED COMPOUNDS, AND METHODS RELATED THERETO | GENOMATICA, INC. (US) | 2011-04-21 | — | — | WO | disclosed |
| WO-2011031897-A1 | MICROORGANISMS AND METHODS FOR THE CO-PRODUCTION OF ISOPROPANOL WITH PRIMARY ALCOHOLS, DIOLS AND ACIDS | GENOMATICA, INC. (US) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011017560-A1 | SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID | GENOMATICA, INC. (US) | 2011-02-10 | — | — | WO | disclosed |
| US-20100323418-A1 | ORGANISMS FOR THE PRODUCTION OF ISOPROPANOL, n-BUTANOL, AND ISOBUTANOL | GENOMATICA, INC. (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100317069-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | AGAIN BIO APS (DK) | 2010-12-16 | — | — | US | disclosed |
| US-20100304453-A1 | MICROORGANISMS AND METHODS FOR CONVERSION OF SYNGAS AND OTHER CARBON SOURCES TO USEFUL PRODUCTS | GENOMATICA, INC. (US) | 2010-12-02 | — | — | US | disclosed |
| WO-2010129936-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | GENOMATICA, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| WO-2010127303-A1 | ORGANISMS FOR THE PRODUCTION OF ISOPROPANOL, N-BUTANOL, AND ISOBUTANOL | GENOMATICA, INC. (US) | 2010-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388910-A1 | METHODS FOR ENHANCING MICROBIAL PRODUCTION OF SPECIFIC LENGTH FATTY ALCOHOLS IN THE PRESENCE OF METHANOL | ADH5, ADH1C, ADH1A | EP300 1466/4885AURKA 3847/4885CHAT 1999/4885 |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | DDC, DAO, ODC1 | EP300 1948/4885AURKA 1208/4885CHAT 77/4885 |
| US-20260103733-A1 | METHODS AND ORGANISMS WITH INCREASED CARBON FLUX EFFICIENCIES | PCK1, PC, PCK2 | EP300 3357/4885AURKA 1528/4885CHAT 2024/4885 |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | HSD17B10, HSD17B12, HADHB | EP300 2217/4885AURKA 2812/4885CHAT 2185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.